Fact CheckerSign in

NCT05726136RecruitingPhase 4

Fluid Challenge and Plasma Volume, During Surgery

Comparison of Albumin and Ringer's Solution for Optimization of the Plasma Volume and Hemodynamics During Laparoscopic Surgery.

Source: ClinicalTrials.gov · Last updated 30 Apr 2026

Brief summary (registry, in English)

A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
First submitted
15 Jan 2023
Start date
23 Oct 2023
Primary completion date
31 Oct 2026
Lead sponsor
Joachim Zdolsek
NCT number
NCT05726136

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 60
  • From 23 Oct 2023 to the primary completion date, 31 Oct 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with known cardiac failure
  • kidney failure

Lab values

  • known allergy to albumin

Age

  • \<18 or \>85 years

Other

  • extracellular hyperhydration or hypervolemia
  • pregnancy or planned pregnancy

Who the study is looking for

  • Written consent to participate in the study
  • For women: relevant contraceptive, menopausal or a negative pregnancy test.
  • ASA category I to III
  • Laparoscopic abdominal surgery, with a duration of at least 90 minutes.
  • 18 to 85 years

Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vrinnevi Hospital
Coordinator of this site? Confirm its status
NorrköpingSwedenRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.